Related Experiment Video
Updated: Jun 16, 2026

Transcorporal Artificial Urinary Sphincter Cuff Placement in a Case Requiring Revision for Urethral Atrophy
Published on: June 16, 2022
New drug treatments for urinary incontinence
Dudley Robinson1, Linda Cardozo
1Department of Urogynaecology, 3rd Floor, Golden Jubilee Wing, Kings College Hospital, London, UK. dudley.robinson@nhs.net
Abstract:
Urinary incontinence remains a common and distressing condition affecting many women and is known to have a significant effect on quality of life (QoL). Whilst conservative and behavioural therapy are important in the management of women with both stress incontinence and overactive bladder (OAB) ultimately many may benefit from pharmacological therapy. Antimuscarinic drugs are the commonly used agents in the treatment of OAB although often compliance and persistence are affected by adverse effects. Consequently many newer agents remain under investigation. In addition duloxetine has recently been introduced for the management of women with stress incontinence and may offer an alternative to surgery in selected cases. The aim of this review is to provide an overview of the current and new developments in the management of women with urinary incontinence as well as reviewing the role of oestrogen therapy in relation to lower urinary tract dysfunction.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Intrauterine Drug Delivery Systems
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Drugs for Treatment of Constipation-Predominant IBS
Urinary Tract Calculi III: Medical Management
Urinary Tract Infection IV: Nursing Management